SPDR® S&P Biotech ETF (XBI)

Add to Watchlists
Create an Alert
62.12 +0.33  +0.53% NYSE Arca Dec 8, 16:59 Delayed 2m USD
View Full Chart
XBI Price Chart

XBI Key Stats

Expense Ratio 0.35%
Share Class Assets Under Management 2.744B
30-Day Average Daily Volume Upgrade
Net Asset Value 61.87
Discount or Premium to NAV 0.03%
Turnover Ratio 75.00

XBI Performance

  Total Return Cat. Total Return (NAV) % Rank in Cat. (NAV) Cat. Total Return (Price) % Rank in Cat. (Price)
1M 7.76% -- 7 -- 3
3M -1.42% -- 8 -- 3
6M 5.55% -- 3 -- 4
1Y -12.90% -- 31 -- 46
3Y 13.73% -- 1 -- 1
5Y 24.17% -- 1 -- 1
As of Dec. 2, 2016
Returns for periods of 1 year and above are annualized.

XBI Asset Allocation

Type % Net % Long % Short
Cash 0.00 0.00 0.00
Stock 99.98% 99.98% 0.00
Bond 0.00 0.00 0.00
Convertible 0.00 0.00 0.00
Preferred 0.00 0.00 0.00
Other 0.02% 0.02% 0.00
As of Dec. 7, 2016

XBI Region Exposure

Americas 100.0%
North America 100.0%
Latin America 0.00
Greater Europe 0.00
United Kingdom 0.00
Europe Developed 0.00
Europe Emerging 0.00
Africa/Middle East 0.00
Greater Asia 0.00
Japan 0.00
Australasia 0.00
Asia Developed 0.00
Asia Emerging 0.00
Market Classification
% Developed Markets 100.0%
% Emerging Markets 0.00
As of Dec. 7, 2016
Region breakdown data is calculated by using the long position holdings of the portfolio.

XBI Stock Sector Exposure

Basic Materials 0.00
Communication Services 0.00
Consumer Cyclical 0.00
Consumer Defensive 0.00
Energy 0.00
Financial Services 0.00
Healthcare 100.0%
Industrials 0.00
Real Estate 0.00
Technology 0.00
Utilities 0.00
As of Dec. 7, 2016

XBI Stock Market Capitalization

Giant 9.36%
Large 12.30%
Medium 23.06%
Small 37.39%
Micro 17.89%
As of Dec. 7, 2016

XBI Stock Style Exposure

Large Cap Value 0.00
Large Cap Blend 2.33%
Large Cap Growth 21.90%
Mid Cap Value 3.02%
Mid Cap Blend 3.45%
Mid Cap Growth 19.34%
Small Cap Value 0.20%
Small Cap Blend 13.97%
Small Cap Growth 35.79%
As of Dec. 7, 2016
View More Holdings

XBI Top 10 Holdings

Symbol Name % Weight Price % Chg
IONS Ionis Pharmaceuticals Inc 3.90% 46.55 +1.20%
TSRO Tesaro Inc 3.62% 131.62 -2.40%
INCY Incyte Corp 3.17% 102.95 +0.97%
EXEL Exelixis Inc 3.08% 16.91 +1.81%
SRPT Sarepta Therapeutics Inc 3.07% 34.52 +1.80%
BLUE bluebird bio Inc 2.86% 71.80 +1.84%
UTHR United Therapeutics Corp 2.69% 131.79 +0.21%
CELG Celgene Corp 2.65% 113.08 +0.37%
ALXN Alexion Pharmaceuticals Inc 2.47% 125.98 +0.29%
BIIB Biogen Inc 2.37% 289.30 +1.40%
As of Dec. 7, 2016
Advertisement

XBI One Page Reports

XBI Basic Info

Style
Equity Style Mid Cap/Growth
Broad Asset Class Sector Equity
Broad Category Equity
Category Name Health
Prospectus Objective Specialty - Health
Fund Owner Firm Name SPDR State Street Global Advisors
Benchmark Index
S&P Biotechnology Select Industry TR USD
100.0%

XBI Manager Info

Name Tenure
John Tucker 10.76 yrs
Karl Schneider 2.01 yrs
Michael Feehily 5.01 yrs

XBI Net Fund Flows

1M 485.25M
3M 963.02M
6M 955.94M
YTD 1.118B
1Y 1.097B
3Y 1.807B
5Y 1.933B
10Y 2.334B
As of Nov. 30, 2016

XBI Risk Info

Beta (5Y) 1.629
Max Drawdown (All) 49.39%
Historical Sharpe (10Y) 0.626
Historical Sortino (All) 0.8579
30-Day Rolling Volatility 47.23%
Daily Value at Risk (VaR) 1% (All) 4.92%
Monthly Value at Risk (VaR) 1% (All) 21.62%

XBI Fundamentals

Dividend Yield TTM (12-8-16) 0.46%
SEC Yield (6-2-16) 0.18%
Weighted Average PE Ratio --
Weighted Average Price to Sales Ratio 9.038
Weighted Average Price to Book Ratio 5.067
Weighted Median ROE -4.07%
Weighted Median ROA -16.61%
Forecasted Dividend Yield 0.18%
Forecasted PE Ratio 21.66
Forecasted Price to Sales Ratio 7.900
Forecasted Price to Book Ratio 2.968
Number of Holdings 84
As of Dec. 7, 2016

XBI Growth Estimates

Forecasted 5 Yr Earnings Growth 19.89%
Forecasted Book Value Growth 28.89%
Forecasted Cash Flow Growth 28.53%
Forecasted Earnings Growth 32.68%
Forecasted Revenue Growth 17.60%
As of Dec. 7, 2016

XBI Comparables

Edit

XBI Attributes

Key Dates
Inception Date 1/31/2006
Last Annual Report Date 6/30/2016
Last Prospectus Date 10/31/2016
Attributes
Exchange Traded Share Yes
Exchange Traded Note No
Enhanced Index Fund No
Index Fund Yes
Inverse Fund No
Leveraged Fund No
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan Yes
General Availability
Available for Insurance Product No
Available for Retirement Plan No
Available for RRSP No

XBI Excel Add-In Codes

  • Name: =YCI("XBI","name")
  • Broad Asset Class: =YCI("XBI", "broad_asset_class")
  • Broad Category: =YCI("XBI", "broad_category_group")
  • Prospectus Objective: =YCI("XBI", "prospectus_objective")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 7-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 7-Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.